Genome-Wide Disease Screening in Early Human Embryos with Primary Template-Directed Amplification

Current preimplantation genetic testing (PGT) enables the selection of embryos based on fetal aneuploidy or the presence a small number of preselected disease-associated variants. Here we present a new approach that takes advantage of the improved genome coverage and uniformity of primary template-directed amplification (PTA) to call most early embryo genetic variants accurately and reproducibly from a preimplantation biopsy. With this approach, we identified clonal and mosaic chromosomal aneuploidy, de novo mitochondrial variants, and variants predicted to cause mendelian and non-mendelian diseases. In addition, we utilized the genome-wide information to compute polygenic risk scores for common diseases. Although numerous computational, interpretive, and ethical challenges remain, this approach establishes the technical feasibility of screening for and preventing numerous debilitating inherited diseases.

[1]  Lovelace J. Luquette,et al.  Ultraspecific somatic SNV and indel detection in single neurons using primary template-directed amplification , 2021, bioRxiv.

[2]  Charles Gawad,et al.  Accurate genomic variant detection in single cells with primary template-directed amplification , 2020, Proceedings of the National Academy of Sciences.

[3]  Genlin Li,et al.  Molecular diagnosis based on comprehensive genetic testing in 800 Chinese families with non‐syndromic inherited retinal dystrophies , 2020, Clinical & experimental ophthalmology.

[4]  L. Rombauts,et al.  Genome sequencing of human in vitro fertilisation embryos for pathogenic variation screening , 2020, Scientific Reports.

[5]  J. Danesh,et al.  Genomic risk score offers predictive performance comparable to clinical risk factors for ischaemic stroke , 2019, Nature Communications.

[6]  C. Racowsky,et al.  Noninvasive preimplantation genetic testing for aneuploidy in spent medium may be more reliable than trophectoderm biopsy , 2019, Proceedings of the National Academy of Sciences.

[7]  Matthew S. Lebo,et al.  Polygenic Prediction of Weight and Obesity Trajectories from Birth to Adulthood , 2019, Cell.

[8]  Samuel E. Jones,et al.  Development and Standardization of an Improved Type 1 Diabetes Genetic Risk Score for Use in Newborn Screening and Incident Diagnosis , 2019, Diabetes Care.

[9]  Helen E. Parkinson,et al.  The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019 , 2018, Nucleic Acids Res..

[10]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[11]  Mary E. Haas,et al.  Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations , 2018, Nature Genetics.

[12]  K. D. Sørensen,et al.  Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci , 2018, Nature Genetics.

[13]  E. Topol,et al.  The personal and clinical utility of polygenic risk scores , 2018, Nature Reviews Genetics.

[14]  R. McCoy.  Mosaicism in Preimplantation Human Embryos: When Chromosomal Abnormalities Are the Norm. , 2017, Trends in genetics : TIG.

[15]  W. Yeung,et al.  Preimplantation genetic diagnosis for monogenic diseases. , 2017, Best practice & research. Clinical obstetrics & gynaecology.

[16]  P. Stenson,et al.  The Human Gene Mutation Database: towards a comprehensive repository of inherited mutation data for medical research, genetic diagnosis and next-generation sequencing studies , 2017, Human Genetics.

[17]  Lilah M. Besser,et al.  Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score , 2017, PLoS medicine.

[18]  Correction: Genetic assessment of age-associated Alzheimer disease risk: Development and validation of a polygenic hazard score , 2017, PLoS medicine.

[19]  Koenraad Devriendt,et al.  Prenatal and pre-implantation genetic diagnosis , 2016, Nature Reviews Genetics.

[20]  Jurg Ott,et al.  Genetic linkage analysis in the age of whole-genome sequencing , 2015, Nature Reviews Genetics.

[21]  Rebecca Yu Zhang,et al.  Detection and phasing of single base de novo mutations in biopsies from human in vitro fertilized embryos by advanced whole-genome sequencing , 2015, Genome research.

[22]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[23]  François Schiettecatte,et al.  OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders , 2014, Nucleic Acids Res..

[24]  C. Spencer,et al.  Biological Insights From 108 Schizophrenia-Associated Genetic Loci , 2014, Nature.

[25]  Jana Marie Schwarz,et al.  MutationTaster2: mutation prediction for the deep-sequencing age , 2014, Nature Methods.

[26]  Deanna M. Church,et al.  ClinVar: public archive of relationships among sequence variation and human phenotype , 2013, Nucleic Acids Res..

[27]  Mahdi Sarmady,et al.  mtDNA Variation and Analysis Using Mitomap and Mitomaster , 2013, Current protocols in bioinformatics.

[28]  D. Wells,et al.  The origin and impact of embryonic aneuploidy , 2013, Human Genetics.

[29]  D. MacArthur,et al.  Loss of ACTN3 gene function alters mouse muscle metabolism and shows evidence of positive selection in humans , 2007, Nature Genetics.

[30]  M. Castellano,et al.  Genetic Mutation Screening in an Italian Cohort of Nonsyndromic Pheochromocytoma/Paraganglioma Patients , 2006, Annals of the New York Academy of Sciences.

[31]  Rajiv K. Saxena,et al.  Gene conversions are a common cause of von Willebrand disease , 2005, British journal of haematology.

[32]  Paul S. Bernstein,et al.  Mutation of the Stargardt Disease Gene (ABCR) in Age-Related Macular Degeneration , 1997 .